252 related articles for article (PubMed ID: 29666781)
41. Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice.
Takada H; Galanos C
Infect Immun; 1987 Feb; 55(2):409-13. PubMed ID: 3804443
[TBL] [Abstract][Full Text] [Related]
42. The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells.
Lee SH; Park JH; Park SR
J Immunol Res; 2019; 2019():2724078. PubMed ID: 31886297
[TBL] [Abstract][Full Text] [Related]
43. Effects of synthetic muramyl dipeptide on bone metabolism in the fetal rat.
Dziak R; Rowe DJ; Brown MJ; Hausmann E
Arch Oral Biol; 1982; 27(10):787-91. PubMed ID: 6297436
[TBL] [Abstract][Full Text] [Related]
44. Differences between macrophage migration inhibitions by lymphokines and muramyl dipeptide (MDP) or lipopolysaccharide (LPS): migration enhancement by lymphokines.
Nagao S; Tanaka A; Onozaki K; Hashimoto T
Cell Immunol; 1982 Jul; 71(1):1-11. PubMed ID: 6754096
[No Abstract] [Full Text] [Related]
45. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
46. Dual modulation of osteoclast differentiation by lipopolysaccharide.
Zou W; Bar-Shavit Z
J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
[TBL] [Abstract][Full Text] [Related]
47. Muramyl dipeptide potentiates staphylococcal lipoteichoic acid induction of cyclooxygenase-2 expression in macrophages.
Ahn KB; Jeon JH; Baik JE; Park OJ; Kang SS; Yun CH; Park JH; Han SH
Microbes Infect; 2014 Feb; 16(2):153-60. PubMed ID: 24211871
[TBL] [Abstract][Full Text] [Related]
48. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.
Zhuang L; Jung JY; Wang EW; Houlihan P; Ramos L; Pashia M; Chole RA
Laryngoscope; 2007 May; 117(5):841-7. PubMed ID: 17473680
[TBL] [Abstract][Full Text] [Related]
49. [The stimulating action of lipopolysaccharide and muramyl dipeptide on the activation of mononuclear cells in human peripheral blood by recombinant interleukin-2 in vitro].
Rakhmilevich AL; Pelevina MA; Artsimovich NG; Fuks BB
Biull Eksp Biol Med; 1988 Dec; 106(12):698-701. PubMed ID: 3061497
[TBL] [Abstract][Full Text] [Related]
50. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A
J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
[TBL] [Abstract][Full Text] [Related]
51. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
52. MURAMYL DIPEPTIDE CAUSES MITOCHONDRIAL DYSFUNCTION AND INTESTINAL INFLAMMATORY CYTOKINE RESPONSES IN RATS.
Zhao LJ; Dai XY; Ye YW; Pang XF; Jiang M; Tan WY; Xu YH; Su JF; Shi B
Shock; 2024 Jul; 62(1):139-145. PubMed ID: 38546380
[TBL] [Abstract][Full Text] [Related]
53. Production and characterization of cytostatic protein factors released from human monocytes during exposure to lipopolysaccharide and muramyl dipeptide.
Kildahl-Andersen O; Nissen-Meyer J
Cell Immunol; 1985 Jul; 93(2):375-86. PubMed ID: 3873995
[TBL] [Abstract][Full Text] [Related]
54. Muramyl dipeptide-elicited production of PGD2 from astrocytes in culture.
Yamamoto K; Miwa T; Ueno R; Hayaishi O
Biochem Biophys Res Commun; 1988 Oct; 156(2):882-8. PubMed ID: 3056405
[TBL] [Abstract][Full Text] [Related]
55. Bacteroides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and -nonresponsive mice primed with muramyl dipeptide.
Takada H; Hirai H; Fujiwara T; Koga T; Ogawa T; Hamada S
J Infect Dis; 1990 Aug; 162(2):428-34. PubMed ID: 2197336
[TBL] [Abstract][Full Text] [Related]
56. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
57. IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
Saeed J; Kitaura H; Kimura K; Ishida M; Sugisawa H; Ochi Y; Kishikawa A; Takano-Yamamoto T
Immunol Lett; 2016 Jul; 175():8-15. PubMed ID: 27154248
[TBL] [Abstract][Full Text] [Related]
58. Effects of a bacterial cell wall fragment on monocyte inflammatory function.
Safavi KE; Nichols FC
J Endod; 2000 Mar; 26(3):153-5. PubMed ID: 11199709
[TBL] [Abstract][Full Text] [Related]
59. Bacterial cell wall products increase monocyte HLA-DR and ICAM-1 without affecting lymphocyte CD18 expression.
Heinzelmann M; Mercer-Jones MA; Gardner SA; Wilson MA; Polk HC
Cell Immunol; 1997 Mar; 176(2):127-34. PubMed ID: 9073385
[TBL] [Abstract][Full Text] [Related]
60. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.
Kats A; Norgård M; Wondimu Z; Koro C; Concha Quezada H; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2016 Jun; 20(6):1128-38. PubMed ID: 26987561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
